Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers

Saved in:
Bibliographic Details
Published in:The Oncologist
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871740947647168512
collection WordPress RSS
FRELIP Feed Integration
container_title The Oncologist
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:106646
institution FRELIP
journal_source_facet The Oncologist
last_indexed 2026-07-26T02:01:08.348Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_auth Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_full Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_fullStr Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_full_unstemmed Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_short Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_sort correction to: long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
topic Oncology
General
Oncology
url https://academic.oup.com/oncolo/article/doi/10.1093/oncolo/oyag061/8741392?rss=1